Discovery of biphenylketones as dual modulators of inflammation and bone loss

Iain R Greig, Emmanuel Coste, Stuart H Ralston, Rob J van't Hof

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Biphenylketones were identified as novel inhibitors of NFkappaB activation. Structure-activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC50=0.8 microM), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo.
Original languageEnglish
Pages (from-to)5548-5551
Number of pages4
JournalBioorganic & Medicinal Chemistry Letters
Volume20
Issue number18
Early online date18 Jul 2010
DOIs
Publication statusPublished - 15 Sep 2010

Fingerprint

Osteitis
Osteoclasts
Modulators
Inhibitory Concentration 50
Bone
Chemical activation

Keywords

  • inflammation
  • bone loss
  • rheumatoid arthritis
  • TNFa
  • NFκB
  • RANKL

Cite this

Discovery of biphenylketones as dual modulators of inflammation and bone loss. / Greig, Iain R; Coste, Emmanuel; Ralston, Stuart H; van't Hof, Rob J.

In: Bioorganic & Medicinal Chemistry Letters, Vol. 20, No. 18, 15.09.2010, p. 5548-5551.

Research output: Contribution to journalArticle

Greig, Iain R ; Coste, Emmanuel ; Ralston, Stuart H ; van't Hof, Rob J. / Discovery of biphenylketones as dual modulators of inflammation and bone loss. In: Bioorganic & Medicinal Chemistry Letters. 2010 ; Vol. 20, No. 18. pp. 5548-5551.
@article{a303e7229925424bb3004c83a7b0944b,
title = "Discovery of biphenylketones as dual modulators of inflammation and bone loss",
abstract = "Biphenylketones were identified as novel inhibitors of NFkappaB activation. Structure-activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC50=0.8 microM), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo.",
keywords = "inflammation, bone loss, rheumatoid arthritis, TNFa, NFκB, RANKL",
author = "Greig, {Iain R} and Emmanuel Coste and Ralston, {Stuart H} and {van't Hof}, {Rob J}",
note = "Copyright (c) 2010 Elsevier Ltd. All rights reserved.",
year = "2010",
month = "9",
day = "15",
doi = "10.1016/j.bmcl.2010.07.055",
language = "English",
volume = "20",
pages = "5548--5551",
journal = "Bioorganic & Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "18",

}

TY - JOUR

T1 - Discovery of biphenylketones as dual modulators of inflammation and bone loss

AU - Greig, Iain R

AU - Coste, Emmanuel

AU - Ralston, Stuart H

AU - van't Hof, Rob J

N1 - Copyright (c) 2010 Elsevier Ltd. All rights reserved.

PY - 2010/9/15

Y1 - 2010/9/15

N2 - Biphenylketones were identified as novel inhibitors of NFkappaB activation. Structure-activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC50=0.8 microM), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo.

AB - Biphenylketones were identified as novel inhibitors of NFkappaB activation. Structure-activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC50=0.8 microM), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo.

KW - inflammation

KW - bone loss

KW - rheumatoid arthritis

KW - TNFa

KW - NFκB

KW - RANKL

U2 - 10.1016/j.bmcl.2010.07.055

DO - 10.1016/j.bmcl.2010.07.055

M3 - Article

VL - 20

SP - 5548

EP - 5551

JO - Bioorganic & Medicinal Chemistry Letters

JF - Bioorganic & Medicinal Chemistry Letters

SN - 0960-894X

IS - 18

ER -